These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 6198071

  • 1. Correlation of serum tumor markers in advanced germ cell tumors with responses to chemotherapy and surgery.
    Vugrin D, Friedman A, Whitmore WF.
    Cancer; 1984 Mar 15; 53(6):1440-5. PubMed ID: 6198071
    [Abstract] [Full Text] [Related]

  • 2. Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers.
    Wood DP, Herr HW, Motzer RJ, Reuter V, Sogani PC, Morse MJ, Bosl GJ.
    Cancer; 1992 Nov 01; 70(9):2354-7. PubMed ID: 1382832
    [Abstract] [Full Text] [Related]

  • 3. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
    Habuchi T, Kamoto T, Hara I, Kawai K, Nakao M, Nonomura N, Kobayashi T, Ogawa O, Kamidono S, Akaza H, Okuyama A, Kato T, Miki T.
    Cancer; 2003 Oct 15; 98(8):1635-42. PubMed ID: 14534879
    [Abstract] [Full Text] [Related]

  • 4. Primary chemotherapy for clinical stage II nonseminomatous germ cell tumors of the testis: a follow-up of 50 patients.
    Logothetis CJ, Swanson DA, Dexeus F, Chong C, Ogden S, Ayala AG, von Eschenbach AC, Johnson DE, Samuels ML.
    J Clin Oncol; 1987 Jun 15; 5(6):906-11. PubMed ID: 2438389
    [Abstract] [Full Text] [Related]

  • 5. [In which marker-positive patients with germ cell tumors is residual tumor resection of value?].
    Weinknecht S, Hartmann M, Weissbach L.
    Urologe A; 1998 Nov 15; 37(6):621-4. PubMed ID: 9887490
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
    Szymendera JJ, Zborzil J, Sikorowa L, Leńko J, Kamińska JA, Gadek A.
    Oncology; 1983 Nov 15; 40(1):1-10. PubMed ID: 6185897
    [Abstract] [Full Text] [Related]

  • 7. Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
    Kobayashi T, Kawakita M, Terachi T, Habuchi T, Ogawa O, Kamoto T.
    J Surg Oncol; 2006 Dec 01; 94(7):619-23. PubMed ID: 17111392
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of pregnancy-specific beta 1-glycoprotein in patients with non-seminomatous testicular germ cell tumors.
    de Bruijn HW, Suurmeijer AJ, Sleijfer DT, Koops HS, Ockhuizen T, Willemse PH, Marrink J.
    Eur J Cancer Clin Oncol; 1982 Oct 01; 18(10):911-6. PubMed ID: 6186495
    [Abstract] [Full Text] [Related]

  • 9. Postchemotherapy Residual Tumor Resection in Patients with Elevated Tumor Markers.
    Che Y, Buddensieck C, Albers P, Lusch A, Winter C, Siemer RG, Hiester A.
    J Urol; 2022 Mar 01; 207(3):617-626. PubMed ID: 34694152
    [Abstract] [Full Text] [Related]

  • 10. Significance of human chorionic gonadotropin, alpha-fetoprotein, and pregnancy-specific beta-1-glycoprotein in the detection of tumor relapse and partial remission in 126 patients with nonseminomatous testicular germ cell tumors.
    de Bruijn HW, Sleijfer DT, Schraffordt Koops H, Suurmeijer AJ, Marrink J, Ockhuizen T.
    Cancer; 1985 Feb 15; 55(4):829-35. PubMed ID: 2578303
    [Abstract] [Full Text] [Related]

  • 11. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW, Zhou FJ, Han H, Qin ZK, Yu SL, Li YH, Ye YL, Teng XY.
    Ai Zheng; 2008 Dec 15; 27(12):1302-6. PubMed ID: 19079998
    [Abstract] [Full Text] [Related]

  • 12. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR, Belitsky P, Millard OH, Lannon SG.
    Can J Surg; 1993 Dec 15; 36(6):537-40. PubMed ID: 7504978
    [Abstract] [Full Text] [Related]

  • 13. Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors.
    Toner GC, Geller NL, Tan C, Nisselbaum J, Bosl GJ.
    Cancer Res; 1990 Sep 15; 50(18):5904-10. PubMed ID: 1697503
    [Abstract] [Full Text] [Related]

  • 14. Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
    You B, Fronton L, Boyle H, Droz JP, Girard P, Tranchand B, Ribba B, Tod M, Chabaud S, Coquelin H, Fléchon A.
    Urology; 2010 Aug 15; 76(2):423-9.e2. PubMed ID: 20472276
    [Abstract] [Full Text] [Related]

  • 15. The growth rate of metastatic nonseminomatous germ cell testicular tumours measured by marker production doubling time--II. Prognostic significance in patients treated by chemotherapy.
    Price P, Hogan SJ, Bliss JM, Horwich A.
    Eur J Cancer; 1990 Apr 15; 26(4):453-7. PubMed ID: 1694087
    [Abstract] [Full Text] [Related]

  • 16. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
    Beck SD, Foster RS, Bihrle R, Donohue JP.
    Urology; 2007 Mar 15; 69(3):557-9. PubMed ID: 17382165
    [Abstract] [Full Text] [Related]

  • 17. Retroperitoneal lymphadenectomy and aggressive chemotherapy in nonbulky clinical Stage II nonseminomatous germinal testis tumors.
    Pizzocaro G, Zanoni F, Milani A, Piva L, Salvioni R, Pasi M, Pilotti S, Monfardini S.
    Cancer; 1984 Mar 15; 53(6):1363-8. PubMed ID: 6198070
    [Abstract] [Full Text] [Related]

  • 18. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA.
    Semin Urol; 1993 May 15; 11(2):92-8. PubMed ID: 7689741
    [No Abstract] [Full Text] [Related]

  • 19. Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors?
    Gerl A, Lamerz R, Clemm C, Mann K, Hartenstein R, Wilmanns W.
    Clin Cancer Res; 1996 Sep 15; 2(9):1565-70. PubMed ID: 9816334
    [Abstract] [Full Text] [Related]

  • 20. The UK Children's Cancer Study Group: testicular malignant germ cell tumours 1979-1988.
    Huddart SN, Mann JR, Gornall P, Pearson D, Barrett A, Raafat F, Barnes JM, Wallendsus KR.
    J Pediatr Surg; 1990 Apr 15; 25(4):406-10. PubMed ID: 1691781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.